The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Centene Corporation (“Centene” or “the Company”) (NYSE: CNC) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Centene is the subject of a Seeking Alpha report published on July 2, 2025. According to the report, the Company’s shares “traded lower on Wednesday after the company withdrew its 2025 earnings guidance, citing a higher-than-anticipated cost trend attributed to its Medicaid enrollees and an unexpected underperformance in its Affordable Care Act plans business.” The Company claimed that its “Medicaid business has experienced a step-up in medical cost trend in the same areas previously identified by the Company: behavioral health, home health, and high-cost drugs.” Based on this news, shares of Centene fell by more than 39.5% in intraday trading on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250702839785/en/